ABSTRACT
The prostate gland has attracted a remarkable increase in interest in the past few years. The two most common diseases of this gland, benign prostatic hyperplasia and carcinoma of the prostate, have been brought into greater prominence by new diagnostic methods, public interest, and a wider choice of surgical and non-surgical treatments. Uncertainty about the significance of these changes has occurred because of the rapidity of change, the profusion of statements, opinions and promotions, and the relatively little guidance available from the profession. Ten urologists and two general practitioners have reviewed the relevant evidence about these two prostate diseases and the newer diagnostic methods; their conclusions are summarised here. Management options and guidance on clinical practice are also discussed. Because of a number of unresolved diagnostic and management issues, detailed requirements for practice guidelines have not been specified.
Subject(s)
Prostatic Diseases/therapy , Adult , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Palpation , Patient Care Team , Primary Health Care , Prostate-Specific Antigen/analysis , Prostatic Diseases/diagnosis , Prostatic Hyperplasia/therapy , Prostatic Neoplasms/therapy , Referral and ConsultationABSTRACT
The Ames Seralyzer uses solid phase chemistry coupled with reflectance spectroscopy to measure levels of serum alanine aminotransferase (serum ALT). The study reported here was carried out to evaluate the performance of the Seralyzer method compared to conventional analyses carried out on a Coulter Dacos discrete random access analyser using Boehringer (BCL) reagents conforming to SCE specications at 37 degrees C. Clinically acceptable accuracy and precision were obtained. The effect of bilirubin and haemoglobin on the test was investigated. Increased levels of bilirubin in sera did not affect the estimation but the presence of high haemoglobin levels produced significant interference. The overall practicality of the Seralyzer was assessed and the method was found to be particularly suitable for the estimation of urgent or high risk samples in the laboratory or for use by suitably trained personnel in other clinical areas.
